Fosun Pharma
40
33M
37
1.33
11
0.07
10
- Areas of investment
Summary
The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Biopharma, Medical. Among the most popular portfolio startups of the fund, we may highlight Butterfly Network, Yaoshibang, Check-Cap. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
We also calculated 14 valuable employees in our database.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Fosun Pharma, startups are often financed by UFG Private Equity, Simul Investments, Pittsburgh Life Sciences Greenhouse. The meaningful sponsors for the fund in investment in the same round are South Valley Angels, Pontifax, Ohio Innovation Fund. In the next rounds fund is usually obtained by Green Pine Capital Partners, DCM Ventures, Yijing Capital.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 40
- Lead investments
- 11
- Exits
- 10
- Rounds per year
- 1.33
- Follow on index
- 0.07
- Investments by industry
- Health Care (21)
- Biotechnology (17)
- Pharmaceutical (12)
- Medical (10)
- Medical Device (7) Show 34 more
- Investments by region
-
- China (26)
- United States (9)
- United Kingdom (1)
- Israel (2)
- France (1) Show 1 more
- Peak activity year
- 2022
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 135M
- Group Appearance index
- 0.60
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.04
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Shanghai Henlius Biotech | 22 Dec 2017 | Biotechnology, Health Care, Medical, Pharmaceutical | Early Stage Venture | 190M | Shanghai, China |
| Abbot's Butcher | 21 Mar 2018 | Food and Beverage, Food Processing, Restaurants | Seed | United States, California, Costa Mesa | |
| Yudao Bio | 14 Jan 2019 | Biotechnology, Health Care, Medical, Biopharma, Alternative Medicine | Seed | Shanghai, Shanghai, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.